VIRULICIDAL EFFECT OF THE PROBIOTIC DRUG "SVITECO-MULTI" ON POLIOVIRUS TYPE 1 AND INFLUENZA VIRUS
DOI 10.17721/1728.2748.2022.91.24-27
Keywords:
Probioric drag, Poliovirus, Bacillus subtilisAbstract
The experimental work shows the antiviral activity of the probiotic drug "Sviteco-Multi" which contains bacteria of the genus Bacillusin model system in cell culturesMDCKandHEp-2, against influenza A (H1N1)pdm2009 virus and vaccine poliovirus type 1, which allows to recommend it for use, in particular, as an alternative to traditional antiviral disinfectants.
References
Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999;284: 1318–1322.
Ayala F., Bauman C., Cogliati S. et al. Microbial flora, probiotics, Bacillus subtilis and the search for a long and healthy human longevity.Microb Cell. 2017 Apr 3; 4(4): 133–136.doi: 10.15698/mic2017.04.569.
Yuan L, Zhang S, Wang Y, Li Y, Wang X, Yang Q. 2018. Surfactin inhibits membrane fusion during invasion of epithelial cells by enveloped viruses. J Virol 92:e00809-18. https://doi.org/10.1128/JVI.00809-18.
Johnson BA, Hage A, Kalveram B, Mears M, Plante JA, Rodriguez SE, Ding Z, Luo X, Bente D, Bradrick SS, Freiberg AN, Popov V, Rajsbaum R, Rossi S, Russell WK, Menachery VD. Peptidoglycan-Associated Cyclic Lipopeptide Disrupts ViralInfectivity. J Virol. 2019 Oct 29;93(22). pii: e01282-19. doi: 10.1128/JVI.01282-19.
Ramya S, Shanmugasundaram T, Balagurunathan R. Biomedical potential of actino bacterially synthesized selenium nanoparticles with special reference to anti-biofilm, anti-oxidant, woundhealing, cytotoxicandantiviralactivities. J TraceElemMedBiol. 2015 Oct;32:30-9. doi: 10.1016/j.jtemb. 2015.05.005. Epub 2015 May 27.
Peng JY, Horng YB, Wu CH, Chang CY, Chang YC, Tsai PS, Jeng CR, Cheng YH, Chang HW. Evaluation of antiviral activity of Bacillus licheniformis‑fermented products against porcine epidemic diarrhea virus. AMB Expr (2019) 9:191, https://doi.org/10.1186/s13568-019-0916-0 .
Starosila D, Rybalko S, Varbanetz L, Ivanskaya N, Sorokulova I. Antiinfluenza Activity of a Bacillus subtilis Probiotic Strain. Antimicrobial Agents and Chemotherapy (2017), V.61. Issue 7. e00539-17.
Silva DS, Castro CC, Silva FS1,VoltaireSant'anna V, Vargas GA, Lima M, Fischer G, Brandelli A, Motta AS, Hübner SO. Antiviral activity of a Bacillus sp. P34 peptide against pathogenic viruses of domestic animals Brazilian Journal of Microbiology. 2014, 45, 3, 1089-1094.
Khodavirdipour A, Chamanrokh P, Alikhani MY, Alikhani MS. Potential of Bacillus subtilis Against SARS-CoV-2- A Sustainable Drug Development Perspective. Frountiers in Microbiology (2022), doi:10.3359/fmicb.2022.7.718786.
Morais IMC, et al. Biological and physicochemical properties of biosurfactants produced by Lactobacillus jensenii P6A and Lactobacillus gasseri P65. Microb Cell Fact. 2017. PMID: 28927409.
Peypoux F., Bonmatin J.M., Wallach J. Recent trends in the biochemistry of surfactin. Appl Microbiol Biotechnol. 1999 May;51(5):553-63.
Fangxiang H., Yuyue L., Shuang L. Rational strain improvement for surfactin production: enhancing the yield and generating novel structures. BMC. MicrobialCellFactories. 2019. https://doi.org/10.1186/s12934-019-1089-x .
EN 14476+A2 Chemical disinfectants and antiseptics – Quantitative suspension test for the evaluation of virucidal activity in the medical area.
Felipe AMM, Rincão VP, Benati FJ, Linhares REC, Galina KJ, Toledo CE, Lopes GC, Mello JC, Nozawa C (2006) Antiviral effect of Guazuma ulmifolia and Stryphnodendron adstringens on poliovirus and bovine herpesvirus. BiolPharmBull 29:1092-1096.
Lehtoranta L., PitkärantaA. &Korpela R. Probiotics in respiratory virus infections. European Journal of Clinical Microbiology & Infectious Diseases. 2014. V. 33, p.1289–1302.
Grossman Ch., Annahtar M., Handley S. etal. Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women. Immunity.2017. Jan.17. V.46. P.29-37.
Tyssen D., Wang Y-Y., Hayward J. et al. Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid. ASM Jornals.2018. V.3.N4.e0055-18.
O'Hanlon DE, Moench TR, Cone RA. 2013. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoSOne 8:e80074.https://doi.org/10.1371/journal.pone.0080074 .
Garcia-Castillo V., Tomokiyo M., Tonetti F. Alveolar Macrophages Are Key Players in the Modulation of the Respiratory Antiviral Immunity Induced by Orally Administered Lacticaseibacillus rhamnosus CRL1505. Frontiers in Immunology.2020. V.11. https://doi: 10.3389/fummu.2020.568636.
Crovella S, Carvalho de Freitas L, Zupin L, Fontana F, Ruscio M , Pena EPN, Pinheiro IO, Junior TC. Surfactin Bacterial Antiviral Lipopeptide Blocks In Vitro Replication of SARS-CoV-2. MDPI. Appl. Microbiol. 2022, 2, 680–687.https://doi.org/10.3390/applmicrobiol2030052 .
